Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC) (original) (raw)

paper cover icon

Androgen receptor splice variant, AR-V7, and resistance to enzalutamide and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC)

Journal of Clinical Oncology

Michael Carducci

Michael Carducci hasn't uploaded this paper.

Let Michael know you want this paper to be uploaded.

Ask for this paper to be uploaded.